Marinus Pharmaceuticals Inc (MRNS)
1.51
+0.06
(+4.14%)
USD |
NASDAQ |
May 03, 16:00
1.515
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Profit Margin (Quarterly): -580.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -580.9% |
| September 30, 2023 | -449.3% |
| June 30, 2023 | -525.1% |
| March 31, 2023 | -334.6% |
| December 31, 2022 | -479.1% |
| September 30, 2022 | |
| June 30, 2022 | -2.20K% |
| Date | Value |
|---|---|
| March 31, 2022 | -136.5% |
| December 31, 2021 | -1.86K% |
| September 30, 2021 | -192.9% |
| June 30, 2021 | -1.25K% |
| March 31, 2021 | -1.50K% |
| December 31, 2020 | -1.13K% |
| September 30, 2020 | -9.16K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.16K%
Minimum
Sep 2020
-136.5%
Maximum
Mar 2022
-1.52K%
Average
-580.9%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 64.72% |
| Soligenix Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | -502.7% |
| ADMA Biologics Inc | -23.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -214.4% |
| Return on Assets | -66.75% |
| Return on Invested Capital | -102.3% |
| Gross Profit Margin (Quarterly) | 87.66% |
| Operating Margin (Quarterly) | -492.9% |
| Return on Net Operating Assets | -950.9% |